Today it was reported that the Sr MD Gen Counsel & Corp Secr of CME Group (CME), Kathleen Cronin, exercised options to sell 8,340 CME shares at $54.30 a share, for a total transaction value of $1.4M.
Following Kathleen Cronin’s last CME Sell transaction on June 01, 2018, the stock climbed by 6.9%. In addition to Kathleen Cronin, 2 other CME executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on CME Group’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $1.25 billion and quarterly net profit of $386 million. In comparison, last year the company earned revenue of $900 million and had a net profit of $2.94 billion. CME’s market cap is $60.71B and the company has a P/E ratio of 29.74. Currently, CME Group has an average volume of 1.08M.
Based on 8 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $194.13, reflecting a 13.8% upside.
The insider sentiment on CME Group has been negative according to 114 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CME Group, Inc. operates as a security and commodity exchange company. It provides the risk management and investment needs of customers around the globe. The company offers a wide range of products across various asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.
